(2021). Healthcare, Medication Utilization and Outcomes of Patients with COPD by GOLD Classification in England. Int J Chron Obstruct Pulmon Dis, 16, 2591-2604. http://doi.org/10.2147/copd.s318969.
(2022). Predictive performance of a competing risk cardiovascular prediction tool CRISK compared to QRISK3 in older people and those with comorbidity: population cohort study. Bmc Med, 20, 152. http://doi.org/10.1186/s12916-022-02349-6.
(2022). Left-sided heart failure burden and mortality in idiopathic pulmonary fibrosis: a population-based study. Bmc Pulm Med, 22, 190. http://doi.org/10.1186/s12890-022-01973-5.
(2022). Longitudinal evaluation of treatment patterns, risk factors and outcomes in patients with cardiovascular disease treated with lipid-lowering therapy in the UK. Bmj Open, 12, e055015. http://doi.org/10.1136/bmjopen-2021-055015.
(2022). Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis. Bmj, 376, e068373. http://doi.org/10.1136/bmj-2021-068373.
(2021). Associations between attainment of incentivized primary care indicators and incident sight-threatening diabetic retinopathy in England: A population-based historical cohort study. Diabetes Obes Metab, 23, 1322-1330. http://doi.org/10.1111/dom.14344.
(2022). Surgical treatment, complications, reoperations, and healthcare costs among patients with clavicle fracture in England. Bmc Musculoskelet Disord, 23, 135. http://doi.org/10.1186/s12891-022-05075-5.
(2022). Factors associated with excess all-cause mortality in the first wave of the COVID-19 pandemic in the UK: A time series analysis using the Clinical Practice Research Datalink. Plos Med, 19, e1003870. http://doi.org/10.1371/journal.pmed.1003870.